Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
One Call Point, One Vision: Precision CEO Kurt Azarbazin’s Plan To Redefine Interventional Oncology
Feb 27 2026
•
By
Marion Webb
CEO Kurt Azarbarzin’s ambition is to build Precision IO into a leader in interventional oncology with a strong focus on precision and remote procedures.
(Shutterstock)
More from Deals
More from Business